Search Results - "Aarons, Donna"
-
1
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry
Published in Biology of blood and marrow transplantation (01-12-2020)“…•We report updated trends in allogeneic stem cell transplantation for myelofibrosis in Australasia.•We identify pretransplantation factors influencing…”
Get full text
Journal Article -
2
A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013
Published in Biology of blood and marrow transplantation (01-02-2016)“…Abstract This report describes hematopoietic cell transplantation (HCT) activity and outcome in Australia and New Zealand during the years 2005 to 2013. In…”
Get full text
Journal Article -
3
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID‐19 pandemic: a report from Australia and New Zealand transplant and cellular therapies
Published in Internal medicine journal (01-03-2023)“…Background The COVID‐19 pandemic has caused major disruption to health systems, with allogeneic haemopoietic cell transplant (alloHCT) services a particularly…”
Get full text
Journal Article -
4
-
5
A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up
Published in Blood (05-11-2020)“…Background HLA-matched sibling and unrelated donors are not always available for patients that are in need of an allogeneic haematopoietic stem cell…”
Get full text
Journal Article -
6
Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index
Published in Blood (23-11-2021)“…Background Patients with secondary acute myeloid leukaemia (sAML), defined as AML that follows a diagnosis of myelodysplastic syndrome or myeloproliferative…”
Get full text
Journal Article -
7
An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era
Published in Blood (13-11-2019)“…Aim: Although allogeneic stem cell transplant (alloSCT) remains the only curative option for myelofibrosis, novel therapeutic agents, the application of new…”
Get full text
Journal Article -
8
Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study
Published in Blood advances (26-09-2023)“…•Haplo-HSCT results in encouraging disease-free survival despite significant hemorrhagic cystitis in the MAC arm.•Early cessation of CNI is feasible in…”
Get full text
Journal Article